Let's connect.

Pharma²⁸ partners with biotech companies, physicians, research centers, healthcare institutions, investors and strategic stakeholders working to advance therapies for rare and ultra-rare diseases. If you are exploring international opportunities for a rare disease therapy, clinical program, data initiative, patient-identification strategy or strategic partnership, we would welcome the opportunity to connect.